Genomictree Inc. (KOSDAQ:228760)
South Korea
· Delayed Price · Currency is KRW 18,000
-1,160 (-6.05%)
Mar 9, 2026, 3:30 PM KST
Genomictree Revenue
Genomictree had revenue of 896.83M KRW in the quarter ending September 30, 2025, with 29.34% growth. This brings the company's revenue in the last twelve months to 3.76B, up 70.89% year-over-year. In the year 2024, Genomictree had annual revenue of 2.36B, down -30.89%.
Revenue (ttm)
3.76B
Revenue Growth
+70.89%
P/S Ratio
116.20
Revenue / Employee
n/a
Employees
n/a
Market Cap
436.80B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SillaJen | 7.84B |
| BINEX | 165.64B |
| Anterogen.Co.,Ltd. | 7.32B |
| GC Cell | 170.13B |
| Green Cross Holdings | 2,397.09B |
| Bioneer | 320.69B |
| JETEMA, | 75.55B |
| Helixmith | 3.74B |